SearchDictionaryMobileLogin

Comparative evaluation of bimatoprost monotherapy in primary chronic angle closure and primary open angle glaucoma eyes: a three-year study.

AbstractAIMS: The aim of this study was to compare the long-term efficacy of bimatoprost 0.03% monotherapy in primary open angle glaucoma (POAG) versus primary chronic angle closure glaucoma (PCACG) eyes. METHODS: A total of 55 consecutive primary adult glaucoma patients on bimatoprost monotherapy were prospectively evaluated in this 3-year, open-labeled, uncontrolled study. The primary outcome was the evaluation of a difference in the response to therapy of POAG eyes, as compared to PCACG eyes over a follow-up of 3 years. RESULTS: In the POAG group, the mean intraocular pressure (IOP) at the 36-month followup was found to be increased by 2.10 (+/-3.90) mmHg (confidence interval [CI], 0.975-4.185), compared to the mean IOP at 1 month (P = 0.047). In the PCACG group, the mean IOP at the 36-month follow-up was increased by 3.66) (+/- 3.34) mmHg (CI, 6.241-1.092), compared to the mean IOP at 1 month (P = 0.011). This upward drift in IOP was higher in the PCACG group, compared to the POAG group, but this was not statistically significant (P = 0.54). Patients with POAG and PCACG showed a 50% and 40% chance of having an IOP of <18 mmHg with bimatoprost monotherapy (P = 0.23), respectively, at the 3-year follow-up. CONCLUSIONS: This study showed that bimatoprost 0.03% monotherapy significantly lowers IOP in both POAG and PCACG eyes over a period of 3 years, though its efficacy appeared to decrease over time, to a similar extent, in both groups.
AuthorsViney Gupta, Geetha Srinivasan, Ajay Sharma, Kulwant S Kapoor, Ramanjit Sihota (Affiliation: Department of Ophthalmology, Glaucoma Research Facility & Clinical Services, Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India. gupta_v20032000 at yahoo.com)
JournalJournal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics (J Ocul Pharmacol Ther) Vol. 23 Issue 4 Pg. 351-8 (Aug 2007) ISSN: 1080-7683 United States
PMID17803433 (Publication Type: Clinical Trial, Comparative Study, Journal Article)
Chemical References
  • Amides
  • Antihypertensive Agents
  • Lipids
  • bimatoprost
  • Cloprostenol
Topics
  • Administration, Topical
  • Aged
  • Amides (adverse effects, therapeutic use)
  • Antihypertensive Agents (adverse effects, therapeutic use)
  • Chronic Disease
  • Cloprostenol (adverse effects, analogs & derivatives, therapeutic use)
  • Female
  • Follow-Up Studies
  • Glaucoma, Angle-Closure (drug therapy)
  • Glaucoma, Open-Angle (drug therapy)
  • Humans
  • Intraocular Pressure (drug effects)
  • Lipids (adverse effects, therapeutic use)
  • Male
  • Middle Aged
  • Prospective Studies
  • Time Factors